Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: JT - Shareholder Letter--Patent Reform

Jul 31, 2007 05:37AM

Jul 31, 2007 04:38PM

Second attempt,

Hi Sge and Billilke,

I think this is really a critical piece to the PTSC future (patent reform).

Patents are being develped by Holocom and by other acquisitions that PTSC acquires. Patriot may itself begin developing new patents to expand our present portfolio ( almost like publish or perish, no new patents, your obsolete). I think the CEO expects to develop a huge patent portfolio through various means that will make the corporation a value stock like ARM initially and later even greater for that matter, where our revenue source to a large degree comes from increasing the PTSC portfolio to become a major force in the tech world.


Aug 01, 2007 04:03AM
Share
New Message
Please login to post a reply